| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8147852 | MYLAN | Modified azole compounds as antifungal and antibacterial agents |
Mar, 2028
(4 years from now) | |
Vusion is owned by Mylan.
Vusion contains Miconazole Nitrate; Petrolatum, White; Zinc Oxide.
Vusion has a total of 1 drug patent out of which 0 drug patents have expired.
Vusion was authorised for market use on 16 February, 2006.
Vusion is available in ointment;topical dosage forms.
Vusion can be used as use for treatment of diaper dermatitis complicated by candidiasis.
The generics of Vusion are possible to be released after 30 March, 2028.
Drugs and Companies using MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE ingredient
Market Authorisation Date: 16 February, 2006
Treatment: Use for treatment of diaper dermatitis complicated by candidiasis
Dosage: OINTMENT;TOPICAL
VUSION family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic